Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax8-PPARγ fusion mRNA?

Endocrine Journal

Volumn 51, Issue 3, 2004, Pages 361-366

  Hibi, Yatsuka ^a   Nagaya, Takashi ^a   Kambe, Fukushi ^a   Imai, Tsuneo ^b   Funahashi, Hiroomi ^b   Nakao, Akimasa ^b   Seo, Hisao ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Pax8 PPAR fusion gene; Thyroid follicular carcinoma

Indexed keywords

HYBRID PROTEIN; MESSENGER RNA; MOLECULAR MARKER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR PAX8;

ADULT; AGED; ARTICLE; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 3; CONTROLLED STUDY; ETHNOLOGY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE EXPRESSION; GOITER; HUMAN; HUMAN TISSUE; JAPAN; MALE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ALTERNATIVE SPLICING; BLOTTING, NORTHERN; DNA-BINDING PROTEINS; EXONS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; JAPAN; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PAIRED BOX TRANSCRIPTION FACTORS; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NEOPLASMS; TRANS-ACTIVATORS; TRANSLOCATION, GENETIC;

EID: 3242765413     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.51.361     Document Type: Article

References (23)

1. Japanese Society of Thyroid Surgery (1996) General rules for the description of thyroid cancer, 8; 5th ed. Tokyo; Kanahara: 14-24.
2. Baloch ZW, Sack MJ, Yu GH, Livolsi VA, Gupta PK (1998) Fine-needle aspiration of thyroid; an institutional experience. Thyroid 8: 565-569.
3. Caraway NP, Sneige N, Samaan NA (1993) Diagnostic pitfalls in thyroid fine-needle aspiration; a review of 394 cases. Diagn Cytopathol 9: 345-350.
4. Busseniers AE, Oertel YC (1993) "Cellular adenomatoid nodules" of the thyroid: review of 219 fine-needle aspirates. Diagn Cytopathol 9: 581-589.
5. Logani S, Gupta PK, LiVolsi VA, Mandel S, Baloch ZW (2000) Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management. Diagn Cytopathol 23: 380-385.
6. Baloch ZW, Abraham S, Roberts S, Livolsi VA (1999) Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Hum Pathol 30: 1166-1171.
7. Fernandez PL, Merino MJ, Gomez M, Campo E, Medina T, Castronovo V, Sanjuan X, Cardesa A, Liu FT, Sobel ME (1997) Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 181: 80-86.
8. Lee A, LiVolsi VA, Baloch ZW (2000) Expression of DNA topoisomerase II alpha in thyroid neoplasia. Mod Pathol 13: 396-400.
9. Sack MJ, Astengo-Osuna C, Lin BT, Battifora H, LiVolsi VA (1997) HBME-I immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod Pathol 10: 668-674.
10. Van Hoeven KH, Kovatich AJ, Miettinen M (1998) Immunocytochemical evaluation of HBME-I, CA19-9 and CD-15 (Leu-M1) in fine-needle aspirates of thyroid nodules. Diagn Cytopathol 18: 93-97.
11. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA (2000) PAX8-PPAR gamma1 fusion oncogene in human thyroid carcinoma. Science 289: 1357-1360.
12. Dwight T, Thoppe SR, Foukakis T, Lui WO, Wallin G, Hoog A, Frisk T, Larsson C, Zedenius J (2003) Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. J Clin Endocrinol Metab 88: 4440-4445.
13. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW 2nd, Tallini G, Kroll TG, Nikiforov YE (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88: 2318-2326.
14. Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R, Robinson BG (2003) Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 88: 354-357.
15. Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE (2002) PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 26: 1016-1023.
16. Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG, Leite V (2002) Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87: 3947-3952.
17. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
18. Yang K, Lui WO, Xie Y, Zhang A, Skytting B, Mandahl N, Larsson C, Larsson O (2002) Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. Oncogene 21: 4181-4190.
19. Kozmik Z, Kurzbauer R, Dorfler P, Busslinger M (1993) Alternative splicing of Pax-8 gene transcripts is developmentally regulated and generates isoforms with different transactivation properties. Mol Cell Biol 13: 6024-6035.
20. Kitamura Y, Shimizu K, Ito K, Tanaka S, Emi M (2001) Allelotyping of follicular thyroid carcinoma: Frequent allelic losses in chromosome arms 7q, 11p, and 22q. J Clin Endocrinol Metab 86: 4268-4272.
21. Ishizaka Y, Ochiai M, Tahira T, Sugimura T, Nagao M (1989) Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing. Oncogene 4: 789-794.
22. Wajjwalku W, Nakamura S, Hasegawa Y, Miyazaki K, Satoh Y, Funahashi H, Matsuyama M, Takahashi M (1992) Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn J Cancer Res 83: 671-675.
23. Namba H, Yamashita S, Pei H, Ishikawa N, Villadolid M, Ishizaki J, Tominaga T, Kimura H, Tsuruta M, Yokoyama N, Izumi M, Ishigaki J, Ito K, Nagataki S (1991) Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors. Endocrinol Jpn 38: 627-632.